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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S77posterior view radiograph of painful knee were measured at baseline
and 3 years later. Experienced readers read the radiographs inde-
pendently recorded the radiographic features of Kellgren & Lawrence
grading (K/L) grade and joint spacewidth (JSW). JSWwas determined at
the center point of the medial femoro-tibial compartment on a radio-
graph using a 0.1-mm graduated magnifying lens.Both serum and urine
samples were obtained on the day that baseline radiographs taken.
Measurement of uCTX-II was used commercial enzyme-linked immu-
nesorbent assay kit (CartiLaps; Nordic Bioscience, Herlev, Denmark).
uCTX-II values were corrected for urine creatinine concentration. As the
distribution of uCTX-II was found to be positively skewed, a logarithmic
transformation (natural log (Ln)) was therefore applied to these bio-
markers to obtain an approximately normal distribution. uCTX-II were
compared using parametric comparisons analysis of variance (ANOVA).
The Bonferroni correction for multiple comparisons was applied. Sig-
niﬁcant differences were evaluated t-test if ANOVAwas signiﬁcant. A P-
value of less than or equal to 0.05 was considered to be statistically
signiﬁcant.
Results: Of the 91patients, 7 showed K/L grade 1,16 showed K/L grade 2,
27 showed K/L grade 3 and 41 showed K/L grade 4 at the baseline. In the
3 years, 41 patients were received total knee arthroplasty (TKA). In the
other patients, 22 patients were progressed their K/L grade one ormore.
The ln-uCTX at baseline was not signiﬁcant differences between K/L
grades. Among the patients with K/L grade 1 to 3, the baseline ln-uCTX-
II levels in the patients with progression of K/L grade were signiﬁcantly
higher than the patients with no progression of K/L grade (p ¼ 0.002).
Conclusions: We demonstrated in the present study that the patients
who were progressed OA presented by K/L grade during 3 years had a
higher uCTX-II, cartilage degradation marker, levels than the others.
These ﬁndings suggest that we could predict OA progression at the ﬁrst
visit in the hospital be using biomarkers. In conclusion, uCTX-II could
predict OA progression.
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Purpose: To investigate the association between urinary degradation
biomarker Coll2-1NO2 (uColl2-1NO2) and incident knee OA after 2.5
years in middle-aged overweight women at high risk for knee OA.
Secondly, to assess association of uColl2-1NO2 with cartilage loss pro-
gression on magnetic resonance imaging (MRI).
Methods: Data were used from PROOF, a 2.5 years randomized con-
trolled trial evaluating the preventive effects of a diet and exercise
program and of oral glucosamine sulphate (double blind and placebo
controlled), on development of knee OA in women with body mass
index  27 kg/m2 and without knee OA at baseline. Baseline, 1 and 2.5
years uColl2-1NO2 levels were assessed with ELISA. Primary outcome
measure was incidence of knee OA in one or both knees, deﬁned as
incidence of either Kellgren & Lawrence grade  2, joint space nar-
rowing of  1.0 mm or clinical knee OA according to the combined
clinical and radiographic ACR-criteria. Secondary outcome measures
were the separate radiographic and clinical items and the MRI pro-
gression of cartilage loss in the patellofemoral and tibiofemoral joint,
using the MRI Osteoarthritis Knee Score (MOAKS). Association between
baseline, follow-up and change of uColl2-1NO2 with primary and sec-
ondary outcomes were assessed using binary logistic regression
analyses.
Results: 254 women were available for primary analysis, 234 women
for MRI analyses. After 2.5 years follow-up, knee OA developed in 72 of
254 women (28.3%) and progression of cartilage defects in 115 of 234
women (49.1%). An inversed association was found between baseline
uColl2-1NO2 and incident knee OA (OR 0.74, 95% CI 0.55 – 0.99) after 2.5
years follow-up. A trend of increasing uColl2-1NO2 during follow-up of
2.5 years was found in incident knee OA and in progression of cartilage
defects (OR 1.10, 95% CI 0.81 – 1.48 and OR 1.26, 95% CI 0.93 – 1.70respectively). This trend of increasing uColl2-1NO2 is also shown in the
ﬁgure.
Conclusion: In overweight middle-aged women, low baseline uColl2-
1NO2 levels were associated with an increased risk for incident knee
OA. We can propose different hypothesis to explain this ﬁnding: 1) an
anabolic compensatory mechanism active in early knee OA, 2) in con-
trast, a decrease of cartilage metabolism could precede cartilage deg-
radation; 3) cartilage volume is lower in people developing knee OA.
Overall, after lower baseline uColl2-1NO2, increasing uColl2-1NO:2
levels seem to dominate in further OA development. Although in early
knee OA changes in uColl2-1NO2 can be found, further exploring of the
biomarker ﬁeld seems necessary to better understand the onset of OA in
high risk patients.123
CORRELATION ANALYSIS OF INFLAMMATION BIOMARKERS WITH
CLINICAL SCORES OF TISSUEGENE-C (TG-C)
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Inc., Gwacheon-si, Republic of Korea
Purpose: Osteoarthritis (OA) is a degenerative joint disease caused by
unbalanced anabolism and catabolism of cartilage with a mild inﬂam-
matory response, but little is known about how the level of inﬂam-
mation is related to severity of OA symptom and tissue destruction. The
level of circulating acute phase protein, C-reactive protein (CRP) has
been widely used as a diagnostic marker in acute inﬂammatory dis-
eases. The matrix metalloproteinase-mediated C-reactive protein
(CRPM) is a hallmark of chronic tissue inﬂammation in the knee joint of
OA patients. TG-C is a cell mediated gene therapy product that contains
non-transduced (hChonJ) and transduced (hChonJb#7) human alloge-
neic chondrocytes. The hChonJb#7 cells were transduced with TGF-b1
gene-containing retroviral vector. The aim of this study was to evaluate
correlation between inﬂammatory biomarkers in OA patients and the
changes of clinical scores of IKDC and WOMAC to estimate the prog-
nostic feature for this TG-C therapy.
Methods: Data from clinical scores of IKDC, WOMAC, IKDC6-0(the
changed value of IKDC score evaluated 6months post treatment of TG-
C) and WOMAC6-0(the changed value of WOMAC score evaluated 6
months post treatment of TG-C) were collected from patients during
TG-C clinical trials, phase IIa (KS-TGC-01-2a) and phase IIb (KS-TGC-01-
2b). The patients enrolled in the clinical trials of TG-C included
advanced joint damage (K&L grade 3, ICRS grade IV in main cartilage
lesion) and various range of knee clinical scores (Table 1). The level of
serum high sensitive CRP (hsCRP) and CRPM were detected by enzyme
linked immunosorbent assay (ELISA). The values were compared
between studies and treatment groups within each study by a non-
